Ivan R. Gonzalez: Lung cancer effectiveness of immunotherapy in early stage

Ivan R. Gonzalez, Medical Oncologist at Comprehensive Oncology Center, Hospital Angeles Puebla, shared a post on X:

”Advances in lung cancer effectiveness of immunotherapy in early stage!

• Inhibition of immune checkpoint is essential in the multimodal treatment of early-stage NSCLC.
• Combining neoadjuvant immunotherapy with platinum-based chemotherapy is recommended over chemotherapy alone.
• This combination reduces the risk of surgical omission and enhances surgical outcomes.
• The introduction of immunotherapy in early-stage NSCLC treatment has improved long-term survival, both event-free and disease-free.
• Many unanswered questions persist regarding the optimal strategy, underscoring the importance of case-by-case discussions in multidisciplinary tumor committees.

Immune checkpoint inhibition in early-stage non-small cell lung cancer.

Authors: Kristof Cuppens, Bert Du Pont, Joost Knegjens, Brigitte Maes, Paul Baas.”

Source: Ivan R. Gonzalez/X